Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF

Step Down FSH Approach and Late Follicular Phase in Progesterone Level

NCT03356964 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol

NCT06879002 ·Status: NOT_YET_RECRUITING

Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle

NCT07028710 ·Status: NOT_YET_RECRUITING ·Phase: NA

Prolonged Protocol of Early Follicular or Mid Luteal Phase

NCT04522479 ·Status: UNKNOWN ·Phase: NA

Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a

NCT05143723 ·Status: UNKNOWN ·Phase: PHASE2

Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.

NCT05980091 ·Status: RECRUITING ·Phase: PHASE1

Progesterone Rise in Agonist Versus Antagonist in Vitro Fertilization (IVF) Cycles

NCT01191710 ·Status: UNKNOWN ·Phase: PHASE4

Triggering of Follicular Maturation

NCT02916173 ·Status: COMPLETED ·Phase: PHASE3

Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation.

NCT02673034 ·Status: COMPLETED

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

NCT00830492 ·Status: COMPLETED ·Phase: PHASE4

Prognostic Value of Progesterone on Oocyte Retrieval Day for In Vitro Fertilization Outcome

NCT02109900 ·Status: UNKNOWN

Low Dose Human Chorionic Gonadotropin: Influence on the Endometrium

NCT00976651 ·Status: COMPLETED ·Phase: PHASE4

Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles

NCT06150703 ·Status: RECRUITING ·Phase: PHASE3

Whole-Brain Dynamics in the Natural Menstrual Cycle vs. an Ovarian Stimulated Cycle: Impact of Hormonal Fluctuations on Healthy Women Undergoing Ovarian Stimulation

NCT06910293 ·Status: RECRUITING

Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI in Granulosa Cells

NCT05330130 ·Status: COMPLETED ·Phase: PHASE1

Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

NCT01037699 ·Status: COMPLETED ·Phase: PHASE3

Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian Response

NCT03373149 ·Status: UNKNOWN ·Phase: PHASE2

Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART

NCT03423537 ·Status: TERMINATED ·Phase: PHASE3

GnRH Agonist for Luteal Phase Support.

NCT05484193 ·Status: UNKNOWN ·Phase: NA

The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles

NCT03209687 ·Status: COMPLETED ·Phase: PHASE4

Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality

NCT03139474 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments

NCT06297564 ·Status: COMPLETED ·Phase: NA

Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation

NCT01319708 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Optimal Length of Progesterone Supplementation Before the Transfer of Cryopreserved(Frozen)-Thawed Embryos in an Artificial Cycle With Exogenous Estrogen and Progesterone.

NCT02032797 ·Status: COMPLETED ·Phase: PHASE4

Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART)

NCT01339299 ·Status: COMPLETED ·Phase: PHASE4